TAFASITAMAB for Covid-19: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 9 adverse event reports in the FDA FAERS database where TAFASITAMAB was used for Covid-19.
Most Reported Side Effects for TAFASITAMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 470 | 33.8% | 239 | 54 |
| Diffuse large b-cell lymphoma | 346 | 24.9% | 206 | 37 |
| Off label use | 203 | 14.6% | 43 | 73 |
| Death | 146 | 10.5% | 146 | 18 |
| Neutropenia | 99 | 7.1% | 19 | 45 |
| Covid-19 | 96 | 6.9% | 33 | 57 |
| General physical health deterioration | 75 | 5.4% | 33 | 33 |
| Pneumonia | 66 | 4.7% | 28 | 45 |
| Febrile neutropenia | 64 | 4.6% | 7 | 55 |
| Drug ineffective | 62 | 4.5% | 40 | 5 |
| Thrombocytopenia | 60 | 4.3% | 13 | 20 |
| Lymphoma | 57 | 4.1% | 7 | 3 |
| Malignant neoplasm progression | 47 | 3.4% | 17 | 12 |
| Infection | 42 | 3.0% | 8 | 14 |
| Diarrhoea | 39 | 2.8% | 5 | 14 |
Other Indications for TAFASITAMAB
Diffuse large b-cell lymphoma (930)
Follicular lymphoma (113)
Product used for unknown indication (86)
Diffuse large b-cell lymphoma refractory (40)
Diffuse large b-cell lymphoma recurrent (37)
Marginal zone lymphoma (24)
Lymphoma (23)
Non-hodgkin's lymphoma (22)
B-cell lymphoma (18)
High-grade b-cell lymphoma (17)
Other Drugs Used for Covid-19
REMDESIVIR (7,196)
HYDROXYCHLOROQUINE (5,280)
BAMLANIVIMAB (4,621)
NIRMATRELVIR\RITONAVIR (4,587)
TOCILIZUMAB (4,186)
DEXAMETHASONE (2,975)
CASIRIVIMAB\IMDEVIMAB (2,943)
SOTROVIMAB (2,732)
AZITHROMYCIN ANHYDROUS (2,510)
METHYLPREDNISOLONE (1,633)